EEOC Indicates Testing Employees for COVID-19 Does Not Violate ADA
2 min read
May 22, 2020
As businesses prepare to re-open, many employers will be concerned about the risk of workplace transmission of the COVID-19 disease. Testing employees before allowing them to enter the workplace is one preventative measure employers are considering. However, this measure has been clouded by uncertainty, because a test for COVID-19 could be considered a medical inquiry under the Americans with Disabilities Act (ADA), which is only permitted if the inquiry is job-related and consistent with business necessity.
In an effort to provide clarity, the Equal Employment Opportunity Commission (EEOC) has now issued guidance regarding employer testing of employees for COVID-19 before they enter the workplace. This guidance states that employers can require employees to undergo a COVID-19 test before entering the workplace without violating the ADA. The EEOC suggests that employers review the Federal Drug Administration's (FDA's) recommendations on testing.
Many laboratories are providing COVID-19 testing. However, it is critical that employers who opt to test employees for COVID-19 use a laboratory that is providing accurate and reliable testing. Generally, COVID-19 testing falls into two categories: diagnostic testing and serology testing. Diagnostic testing checks for the presence of the virus, while serology testing looks for the presence of antibodies that are formed by the body in response to the virus. Serology testing is less certain than diagnostic testing because the body generally takes one to three weeks to develop the antibodies after contracting COVID-19. For instance, a person could undergo a serology test and be found to have no antibodies, even though they could, in fact, be infected with COVID-19. Accordingly, the FDA has stated that serology testing should not be used to diagnose active COVID-19 infections.
Diagnostic testing is generally considered more accurate than serology testing for detecting the presence of the virus. Accordingly, the FDA has issued "Emergency Use Authorizations" (EUA) to certain diagnostic tests of COVID-19. An EUA essentially gives the FDA the authority to allow unapproved products to be used in emergency situations. Laboratories must submit an application with information regarding the effectiveness of their product in order to obtain EUA certification from the FDA. You can view a list of the COVID-19 tests that have received EUA certification on the FDA's website.
Employers will welcome the EEOC's guidance confirming they can require COVID-19 testing of their employees without running afoul of the ADA. At the same time, employers considering COVID-19 testing of employees should ensure that they follow the EEOC's guidance and choose reliable and accurate testing. Although the EEOC guidance does not explicitly state that an "accurate and reliable" test must have EUA certification, employers should still consider using diagnostic tests that have received EUA certification, as these should satisfy the EEOC's guidance.
Topics
Related Capabilities
Featured Insights

Healthcare Alert
Aug 3, 2026
Fixing the Emergency Refill Trap: What California’s AB 1587 Means for Pharmacies

Consumer Crossroads: Where Financial Services and Litigation Intersect
Jul 30, 2026
Should Text Messages be Considered “Calls” Under the TCPA? The Seventh Circuit Says No

Healthcare Alert
Jul 30, 2026
California Courts Sharply Curtail the MICRA Damages Cap in Nursing Home Litigation

Insights for Insurers Alert
Jul 30, 2026
Analyzing a Couple of Cases Involving Exclusions in D&O Policies

In The News
Jul 29, 2026
Hinshaw Authors Contribute Two Articles in Latest Edition of the CCFL Quarterly Report

Webinar
Jul 28, 2026
Cathy Mulrow-Peattie and Sabrina Janeiro Present on Legal AI Technology

In The News
Jul 27, 2026
Scott Seaman Discusses How the Insurance Industry Contributed to the 2026 FIFA World Cup

Privacy, Cyber & AI Decoded Alert
Jul 27, 2026
Compliance Guidance for the New Vermont Data Privacy and Online Surveillance Act (VDPOSA)

Healthcare Alert
Jul 24, 2026
Q&A: Right to Electronic Monitoring Extended to Illinois Assisted and Shared Living Facilities

Press Release
Jul 23, 2026
Insurance Partner Christophe Burusco Joins Hinshaw in Los Angeles

In The News
Jul 16, 2026
Jennifer Driscoll Anticipates Epic Battle Between “Titans of the Antitrust Bar”

